Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms.
暂无分享，去创建一个
J. Qi | J. Bradner | R. Levine | Tony Taldone | G. Chiosis | N. Bhagwat | M. Kleppe | R. Rampal | M. Keller | K. Shank | Hardik J. Patel | Smit K. Shah | Priya Koppikar | Sachie Marubayashi | R. Levine